Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

L1 GROUP LIMITED Capital/Financing Update 2019

Jun 20, 2019

65211_rns_2019-06-20_f63b4f2a-4769-4287-8e2f-c2d39b17e1e0.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

New issue announcement, application for quotation of additional securities and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13

Name of entity

Platinum Asset Management Limited (the Company )

ABN

13 050 064 287

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

1
+Class
of
+securities
issued or to be issued
2
Number
of
+securities
issued or to be issued (if
known)
or
maximum
number which may be
issued
Deferred rights (not quoted) allocated under the
Platinum Asset Management Limited Deferred
Remuneration Plan (Plan) to receive an
equivalent number of the Company’s shares
(Deferred Rights).
Upon the valid exercise of a Deferred Right, an
eligible employee will be entitled to receive one
ordinary share from the employee share trust
(Trust) in satisfaction of the right.
1,623,931 Deferred Rights
  • See chapter 19 for defined terms.

Appendix 3B Page 1

04/03/2013

3
Principal terms of the
+securities
(e.g.
if
options, exercise price
and expiry date; if partly
paid
+securities,
the
amount outstanding and
due dates for payment; if
+convertible
securities,
the conversion price and
dates for conversion)
4
Do the+securities rank
equally in all respects
from the+issue date with
an
existing
+class
of
quoted+securities?
If
the
additional
+securities do not rank
equally, please state:
• the date from which
they do
• the extent to which
they participate for
the next dividend, (in
the case of a trust,
distribution)
or
interest payment
• the extent to which
they
do
not
rank
equally, other than in
relation to the next
dividend, distribution
or interest payment
5
Issue
price
or
consideration
6
Purpose of the issue
(If
issued
as
consideration
for
the
acquisition
of
assets,
clearly
identify
those
assets)
See Annexure A
No, the Deferred Rights do not rank equally in
all respects with the existing class of quoted
securities.
Prior to the Deferred Rights being exercised,
there is no entitlement to vote and receive
dividends.
After the Deferred Rights have vested and been
exercised, the employee will receive an
equivalent number of ordinary shares
(previously purchased on-market).
These ordinary shares will rank equally with the
existing class of quoted securities (including an
entitlement to vote and receive dividends).
Nil
Issue of Deferred Rights under the
Plan in respect of the 2019 financial year.
6a
Is the entity an+eligible
entity that has obtained
security holder approval
under rule 7.1A?
If Yes, complete sections
6b – 6h_in relation to the_
+securities the subject of
this Appendix 3B, and
comply with section 6i
6b
The date the security
holder resolution under
rule 7.1A was passed
6c
Number
of
+securities
issued without security
holder approval under
rule 7.1
6d
Number
of
+securities
issued
with
security
holder approval under
rule 7.1A
6e
Number
of
+securities
issued
with
security
holder approval under
rule
7.3,
or
another
specific security holder
approval (specify date of
meeting)
6f
Number
of
+securities
issued
under
an
exception in rule 7.2
6g
If
+securities
issued
under rule 7.1A, was issue
price at least 75% of 15
day VWAP as calculated
under
rule
7.1A.3?
Include the+issue date
and both values. Include
the source of the VWAP
calculation.
No
Not applicable
Not applicable
Not applicable
Not applicable
Not applicable

Not applicable
  • See chapter 19 for defined terms.

Appendix 3B Page 3

04/03/2013

6h
If+securities were issued
under rule 7.1A for non-
cash consideration, state
date on which valuation
of
consideration
was
released to ASX Market
Announcements
6i
Calculate
the
entity’s
remaining issue capacity
under rule 7.1 and rule
7.1A

complete
Annexure 1 and release to
ASX
Market
Announcements
7
+Issue dates
Note: The issue date may be prescribed by
ASX (refer to the definition of issue date in
rule 19.12). For example, the issue date for a
pro rata entitlement issue must comply with
the applicable timetable in Appendix 7A.
Cross reference: item 33 of Appendix 3B.
8
Number
and
+class
of
all
+securities
quoted
on
ASX
(_including_the
+securities in
section 2 if applicable)
9
Number
and
+class
of
all
+securities not quoted on ASX
(_including_the
+securities in
section 2 if applicable)
10
Dividend policy (in the case of a
trust, distribution policy) on the
increased capital (interests)
Not applicable
Not applicable
20 June 2019
Number +Class
586,678,900 Fully paid ordinary
shares
Number +Class
5,095,797 Deferred Rights
allocated under the
Plan.
Not applicable

Part 2 - Pro rata issue

Items 11 to 33 are not applicable

Part 3 - Quotation of securities

You need only complete this section if you are applying for quotation of securities

34 Type of[+] securities ( tick one )

  • (a) +Securities described in Part 1

(b) All other[+] securities

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

Items 34 to 42 are not applicable.

  • See chapter 19 for defined terms.

Appendix 3B Page 5

04/03/2013

Quotation agreement

  • 1 +Quotation of our additional +securities is in ASX’s absolute discretion. ASX may quote the[+] securities on any conditions it decides.

  • 2 We warrant the following to ASX.

  • The issue of the[+] securities to be quoted complies with the law and is not for an illegal purpose.

  • There is no reason why those[+] securities should not be granted +quotation.

  • An offer of the[+] securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

    • Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty
  • Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any[+] securities to be quoted and that no-one has any right to return any[+] securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the[+] securities be quoted.

  • If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the[+] securities be quoted.

  • 3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

  • 4 We give ASX the information and documents required by this form. If any information or document is not available now, we will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

Sign here: ............................................................ Date: 21/06/2019 (Company secretary)

Print name: Joanne Jefferies.........................................

Appendix 3B – Annexure A

Item 3 – Principal terms of the securities

Nature of Deferred
Rights
Each Deferred Right represents a right to receive one
(1) ordinary share in the capital of the Company,
subject to the terms and conditions of the Plan rules.
Determination of the
Number of Deferred
Rights
The number of Deferred Rights has been determined
by dividing an eligible employees’ Deferred Bonus
award by $4.60 being the volume weighted average
price (VWAP) of the Company’s shares purchased over
the relevant period.
Grant Date 20 June 2019
Acceptance Date 28 June 2019
Vesting Date 20 June 2023
Exercise Expiry Date 20 June 2028
Vesting Conditions Continuous employment until the Vesting Date
Deferred Right Exercise
Price
Nil
Dividend Equivalent
Payment
The Deferred Rights also carry an entitlement to a
dividend equivalent payment.
Upon the valid exercise of a Deferred Right, or deemed
exercise, of a Deferred Right, an eligible employee will
be entitled to receive an amount approximately equal to
the amount of dividends that would have been paid to
the eligible employee had they held the share from the
Grant Date to the date that the Deferred Rights are
exercised.
Funding of Deferred
Rights
In order to satisfy the obligations of the Company
arising from the grant of the Deferred Rights, the
Company intends to, over time, purchase ordinary
shares on-market, to be held in an employee share
trust (Trust).
Upon the valid exercise of a Deferred Right, an eligible
employee will be entitled to receive one ordinary share
from the Trust in satisfaction of the right.
  • See chapter 19 for defined terms.

Appendix 3B Page 7

04/03/2013